Medication administration. |
01/06/2025 |
Final File |
Amendment |
119.03 |
|
01/31/2025 |
|
Y |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication administration. |
10/31/2024 |
Original File |
Amendment |
119.03 |
12/04/2024 |
|
|
Y |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Hearing Summary Report |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication assisted treatment administration. |
05/31/2022 |
Final File |
Amendment |
119.03 |
|
06/10/2022 |
|
N |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication assisted treatment administration. |
04/27/2022 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication assisted treatment administration. |
03/24/2022 |
Original File |
Amendment |
119.03 |
04/25/2022 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Hearing Summary Report |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication assisted treatment administration. |
06/01/2021 |
Final File |
Amendment |
119.03 |
|
06/11/2021 |
|
Y |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication assisted treatment administration. |
03/29/2021 |
Revise |
Amendment |
119.03 |
|
|
|
Y |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Medication assisted treatment administration. |
03/25/2021 |
Original File |
Amendment |
119.03 |
04/27/2021 |
|
|
Y |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Methadone administration. |
11/05/2018 |
Final File |
Amendment |
119.03 |
|
01/01/2019 |
|
N |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Methadone administration. |
10/05/2018 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Methadone administration. |
08/31/2018 |
Original File |
Amendment |
119.03 |
10/02/2018 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Methadone administration. |
05/22/2017 |
Final File |
New |
119.03 |
|
06/01/2017 |
|
N |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Methadone administration. |
04/18/2017 |
Revise |
New |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Methadone administration. |
03/17/2017 |
Original File |
New |
119.03 |
04/25/2017 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|